✦ LIBER ✦

EGFR inhibitors in non-small cell lung cancer (NSCLC): the emerging role of the dual irreversible EGFR/HER2 inhibitor BIBW 2992

✍ Scribed by James F. Spicer; Sarah M. Rudman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The EGFR inhibitor gefitinib suppresses

✍ Yukio Nishimura; Biborka Bereczky; Mayumi Ono 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 940 KB

Quantifying the sensitivities of EGF rec

✍ Gargi Ghosh; Xiaoliang Yan; Andrew G. Lee; Stephen J. Kron; Sean P. Palecek 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 748 KB

The Potential Clinical and Economic Outc

✍ Josh J. Carlson; Louis P. Garrison; Scott D. Ramsey; David L. Veenstra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Overview of molecular testing in non-sma

✍ John, T; Liu, G; Tsao, M-S 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 293 KB